Menn Teknologi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Menn Teknologi Indonesia Tbk. trades at Rp53 (market cap 76B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.2× Menn Teknologi Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MENN | OBAT | |
|---|---|---|
Market Cap | 76B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Menn Teknologi Indonesia Tbk (the Company) was established in the Republic of Indonesia based on the Deed of Establishment No. 2 dated June 23 in Jakarta. The company started its commercial operations in 2015.
Read more on MENN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →